← Leaderboards
Ze'ev A Ronai
Mount Sinai School Of Medicine Of Cuny
$51,589,512
Attributed
$52,668,338
Total exposure
33
Grants
28
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$88,591,084 · 35
By mechanism
R01$30,545,164 · 14
P01$25,354,515 · 6
P30$20,024,566 · 10
R35$10,073,099 · 2
T32$2,560,740 · 2
R03$33,000 · 1
Top collaborators
- Steven H Olson4 shared
Others in their field
Top investigators on “Melanoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$206,517,726
- Richard L Schilsky · University Of Chicago$108,377,382
- Larry Arthur$59,113,709
- Charles A Coltman · Southwest Oncology Group$55,198,633
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$47,956,689
- Meenhard Herlyn · University Of Pennsylvania$46,448,742
Research focus
MelanomaTumorBaseSignal TransductionResponseTranscription FactorStressProteinsRegulationPathway InteractionsNeoplasm MetastasisPlayGeneticProgramsMouse ModelCollaborationsMediatingPhosphorylationFoundationsAffectResistanceLinkUbiquitin LigasePhysiological
Grant awards (150)
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance$1,002,000
R35 · FY2025 · CA · contact PI
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance$826,436
R35 · FY2024 · CA · contact PI
Developmental Funds$766,346
P30 · FY2024 · CA · contact PI
Leadership, Planning and Evaluation$494,198
P30 · FY2024 · CA · contact PI
GCDH Addiction in Melanoma$401,077
R01 · FY2024 · CA · contact PI
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance$343,564
R35 · FY2024 · CA · contact PI
GCDH Addiction in Melanoma$298,503
R01 · FY2024 · CA · contact PI
Cancer Research Career Enhancement and Related Activities (CRCERA)$60,214
P30 · FY2024 · CA · contact PI
Admin Core$31,438
P30 · FY2024 · CA · contact PI
Cancer Center Support Grant (CCSG)$4,081,820
P30 · FY2023 · CA · contact PI
GCDH Addiction in Melanoma$721,672
R01 · FY2023 · CA · contact PI
Cancer Center Support Grant (CCSG)$500,000
P30 · FY2023 · CA · contact PI
Cancer Center Support Grant (CCSG)$4,081,820
P30 · FY2022 · CA · contact PI
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance$1,104,636
R35 · FY2022 · CA · contact PI
GCDH Addiction in Melanoma$736,400
R01 · FY2022 · CA · contact PI
Cancer Center Support Grant (CCSG)$4,081,820
P30 · FY2021 · CA · contact PI
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance$1,129,373
R35 · FY2021 · CA · contact PI
Developmental Funds$781,775
P30 · FY2021 · CA · contact PI
Leadership, Planning and Evaluation$504,147
P30 · FY2021 · CA · contact PI
Cancer Research Career Enhancement and Related Activities (CRCERA)$61,425
P30 · FY2021 · CA · contact PI
Admin Core$32,070
P30 · FY2021 · CA · contact PI
Cancer Center Support Grant (CCSG)$4,081,820
P30 · FY2020 · CA · contact PI
ER Stress and Mitochondrial Biogenesis in Melanoma$1,687,873
P01 · FY2020 · CA · contact PI
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance$1,131,504
R35 · FY2020 · CA · contact PI
Control of Protein Synthesis by the UPS Under Stress$407,536
R01 · FY2020 · CA · contact PI
Project 1 - Siah 1 in ER and Mitochondrial Function and Homeostasis in Melanoma$396,832
P01 · FY2020 · CA · contact PI
Core A - Administrative$214,336
P01 · FY2020 · CA · contact PI
Control of Protein Synthesis by the UPS Under Stress$87,750
R01 · FY2020 · CA · contact PI
ER Stress and Mitochondrial Biogenesis in Melanoma$1,637,236
P01 · FY2019 · CA · contact PI
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance$1,099,568
R35 · FY2019 · CA · contact PI
Control of Protein Synthesis by the UPS Under Stress$445,122
R01 · FY2019 · CA · contact PI
Project 1 - Siah 1 in ER and Mitochondrial Function and Homeostasis in Melanoma$384,928
P01 · FY2019 · CA · contact PI
Core A - Administrative$207,905
P01 · FY2019 · CA · contact PI
ER Stress and Mitochondrial Biogenesis in Melanoma$1,687,873
P01 · FY2018 · CA · contact PI
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance$1,135,587
R35 · FY2018 · CA · contact PI
Control of Protein Synthesis by the UPS Under Stress$438,726
R01 · FY2018 · CA · contact PI
Project 1 - Siah 1 in ER and Mitochondrial Function and Homeostasis in Melanoma$396,832
P01 · FY2018 · CA · contact PI
Core A - Administrative$214,336
P01 · FY2018 · CA · contact PI
ER Stress and Mitochondrial Biogenesis in Melanoma$1,687,873
P01 · FY2017 · CA · contact PI
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance$1,137,453
R35 · FY2017 · CA · contact PI
Control of Protein Synthesis by the UPS Under Stress$438,726
R01 · FY2017 · CA · contact PI
Project 1 - Siah 1 in ER and Mitochondrial Function and Homeostasis in Melanoma$237,930
P01 · FY2017 · CA · contact PI
Core A - Administrative$73,685
P01 · FY2017 · CA · contact PI
ER Stress and Mitochondrial Biogenesis in Melanoma$1,768,606
P01 · FY2016 · CA · contact PI
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance$1,162,978
R35 · FY2016 · CA · contact PI
Project 1 - Siah 1 in ER and Mitochondrial Function and Homeostasis in Melanoma$539,037
P01 · FY2016 · CA · contact PI
Control of Protein Synthesis by the UPS Under Stress$458,622
R01 · FY2016 · CA · contact PI
Core A - Administrative$143,557
P01 · FY2016 · CA · contact PI
Understanding and Targeting the Glutamine Carrier SLC1A5 in Breast Cancer$446,063
R01 · FY2015 · CA · contact PI
ATF2 Oncogenic Addiction in Melanoma$404,625
R01 · FY2015 · CA · contact PI
PDK1 as a Novel Target in Melanoma$381,728
R01 · FY2015 · CA · contact PI
ATF2 Oncogenic Addiction in Melanoma$392,486
R01 · FY2014 · CA · contact PI
PDK1 as a Novel Target in Melanoma$370,276
R01 · FY2014 · CA · contact PI
Novel Insights in the regulation of HIF1alpha Stability$367,335
R01 · FY2014 · CA · contact PI
SIGNAL TRANSDUCTION$108,876
P30 · FY2014 · CA · contact PI
Targeting Pten - An Upstream, Downstream and Offstream Approach$2,051,414
P01 · FY2013 · CA · contact PI
Pten/AKT and Siah in Regulation of Hypoxia$423,991
P01 · FY2013 · CA · contact PI
PDK1 as a Novel Target in Melanoma$408,796
R01 · FY2013 · CA · contact PI
ATF2 Oncogenic Addiction in Melanoma$404,625
R01 · FY2013 · CA · contact PI
Novel Insights in the regulation of HIF1alpha Stability$355,974
R01 · FY2013 · CA · contact PI
SIGNAL TRANSDUCTION$183,599
P30 · FY2013 · CA · contact PI
Administrative Core$81,856
P01 · FY2013 · CA · contact PI
Targeting Pten - An Upstream, Downstream and Offstream Approach$2,187,046
P01 · FY2012 · CA · contact PI
Pten/AKT and Siah in Regulation of Hypoxia$445,252
P01 · FY2012 · CA · contact PI
ATF2 in melanoma development and progression$411,021
R01 · FY2012 · CA · contact PI
Characterization of JNK in Cell Cycle Control$392,486
R01 · FY2012 · CA · contact PI
Novel Insights in the regulation of HIF1alpha Stability$370,927
R01 · FY2012 · CA · contact PI
SIGNAL TRANSDUCTION$120,129
P30 · FY2012 · CA · contact PI
Administrative Core$109,827
P01 · FY2012 · CA · contact PI
SIGNAL TRANSDUCTION$7,940
P30 · FY2012 · CA · contact PI
Targeting Pten - An Upstream, Downstream and Offstream Approach$2,096,667
P01 · FY2011 · CA · contact PI
Pten/AKT and Siah in Regulation of Hypoxia$435,616
P01 · FY2011 · CA · contact PI
ATF2 in melanoma development and progression$402,590
R01 · FY2011 · CA · contact PI
Function of ATF2 URE Binding Protein in Human Melanoma$392,125
R01 · FY2011 · CA · contact PI
Characterization of JNK in Cell Cycle Control$384,435
R01 · FY2011 · CA · contact PI
Trans-disciplinary Postdoctoral Training in Cancer Biology$376,845
T32 · FY2011 · CA · contact PI
Novel Insights in the regulation of HIF1alpha Stability$370,927
R01 · FY2011 · CA · contact PI
Administrative Core$113,515
P01 · FY2011 · CA · contact PI
SIGNAL TRANSDUCTION$21,616
P30 · FY2011 · CA · contact PI
Targeting Pten - An Upstream, Downstream and Offstream Approach$2,166,536
P01 · FY2010 · CA · contact PI
Pten/AKT and Siah in Regulation of Hypoxia$450,208
P01 · FY2010 · CA · contact PI
ATF2 in melanoma development and progression$415,041
R01 · FY2010 · CA · contact PI
Function of ATF2 URE Binding Protein in Human Melanoma$404,252
R01 · FY2010 · CA · contact PI
Characterization of JNK in Cell Cycle Control$396,325
R01 · FY2010 · CA · contact PI
Characterization of RNF5 - A Novel RING Finger Protein$384,693
R01 · FY2010 · CA · contact PI
Novel Insights in the regulation of HIF1alpha Stability$382,399
R01 · FY2010 · CA · contact PI
ATF2 in DNA damage response.$376,879
R01 · FY2010 · CA · contact PI
Trans-disciplinary Postdoctoral Training in Cancer Biology$324,277
T32 · FY2010 · CA · contact PI
Administrative Core$118,139
P01 · FY2010 · CA · contact PI
SIGNAL TRANSDUCTION$23,513
P30 · FY2010 · CA · contact PI
Targeting Pten - An Upstream, Downstream and Offstream Approach$2,124,342
P01 · FY2009 · CA · contact PI
ATF2 in DNA damage response.$463,878
R01 · FY2009 · CA · contact PI
Pten/AKT and Siah in Regulation of Hypoxia$441,443
P01 · FY2009 · CA · contact PI
ATF2 in melanoma development and progression$415,041
R01 · FY2009 · CA · contact PI
Trans-disciplinary Postdoctoral Training in Cancer Biology$403,296
T32 · FY2009 · CA · contact PI
Characterization of JNK in Cell Cycle Control$396,325
R01 · FY2009 · CA · contact PI
Characterization of RNF5 - A Novel RING Finger Protein$384,693
R01 · FY2009 · CA · contact PI
Function of ATF2 URE Binding Protein in Human Melanoma$369,117
R01 · FY2009 · CA · contact PI
Administrative Core$115,887
P01 · FY2009 · CA · contact PI
ATF2 in DNA damage response.$451,222
R01 · FY2008 · CA · contact PI
Characterization of JNK in Cell Cycle Control$396,325
R01 · FY2008 · CA · contact PI
Novel Insights in the regulation of HIF1alpha Stability$371,262
R01 · FY2008 · CA · contact PI
Function of ATF2 URE Binding Protein in Human Melanoma$369,117
R01 · FY2008 · CA · contact PI
Trans-disciplinary Postdoctoral Training in Cancer Biology$336,843
T32 · FY2008 · CA · contact PI
ATF2 in DNA damage response.$447,626
R01 · FY2007 · CA · contact PI
ATF2 in melanoma development and progression$402,953
R01 · FY2007 · CA · contact PI
Function of ATF2 URE Binding Protein in Human Melanoma$391,867
R01 · FY2007 · CA · contact PI
Novel Insights in the regulation of HIF1alpha Stability$371,262
R01 · FY2007 · CA · contact PI
Trans-disciplinary Postdoctoral Training in Cancer Biology$324,842
T32 · FY2007 · CA · contact PI
ATF2 in DNA damage response.$470,643
R01 · FY2006 · CA · contact PI
ATF2 in melanoma development and progression$414,988
R01 · FY2006 · CA · contact PI
JNK as a regulator of p53 stability$394,472
R01 · FY2006 · CA · contact PI
Novel Insights in the regulation of HIF1alpha Stability$382,350
R01 · FY2006 · CA · contact PI
Characterization of RNF5 - a novel RING finger protein$373,489
R01 · FY2006 · CA · contact PI
ATF2 in melanoma development and progression$424,975
R01 · FY2005 · CA
JNK as a regulator of p53 stability$403,965
R01 · FY2005 · CA
Function of ATF2 URE binding protein in human melanoma$396,325
R01 · FY2005 · CA
Novel Insights in the regulation of HIF1alpha Stability$391,550
R01 · FY2005 · CA
Characterization of RNF5 - a novel RING finger protein$382,478
R01 · FY2005 · CA
UV INDUCIBLE INHIBITION IN MELANOMA$375,214
R01 · FY2005 · CA
Novel Insights in the regulation of HIF1alpha Stability$391,550
R01 · FY2004 · CA
ATF2 in melanoma development and progression$377,138
R01 · FY2004 · CA
JNK as a regulator of p53 stability$358,493
R01 · FY2004 · CA
Function of ATF2 URE binding protein in human melanoma$351,713
R01 · FY2004 · CA
UV INDUCIBLE INHIBITION IN MELANOMA$332,978
R01 · FY2004 · CA
Postdoctoral Training Program in Cancer Biology$253,548
T32 · FY2004 · CA
Characterization of RNF5 - a novel RING finger protein$382,478
R01 · FY2003 · CA
ATF2 in melanoma development and progression$377,138
R01 · FY2003 · CA
JNK as a regulator of p53 stability$358,493
R01 · FY2003 · CA
Function of ATF2 URE binding protein in human melanoma$351,713
R01 · FY2003 · CA
Characterization of RNF5 - a novel RING finger protein$339,424
R01 · FY2003 · CA
UV INDUCIBLE INHIBITION IN MELANOMA$332,978
R01 · FY2003 · CA
Postdoctoral Training Program in Cancer Biology$264,449
T32 · FY2003 · CA
Function of ATF2 URE binding protein in human melanoma$351,713
R01 · FY2002 · CA
Characterization of RNF5 - a novel RING finger protein$339,424
R01 · FY2002 · CA
UV INDUCIBLE INHIBITION IN MELANOMA$332,978
R01 · FY2002 · CA
JNK AS KEY REGULATOR OF P53 STABILITY$291,077
R01 · FY2002 · CA
Postdoctoral Training Program in Cancer Biology$276,640
T32 · FY2002 · CA
MDM2/TAFII31 regulation of p53 stability$237,979
P01 · FY2002 · CA
GSTPI--A REGULATOR OF JNK SIGNALING$364,418
R01 · FY2001 · CA
Function of ATF2 URE binding protein in human melanoma$343,060
R01 · FY2001 · CA
UV INDUCIBLE INHIBITION IN MELANOMA$332,978
R01 · FY2001 · CA
JNK AS KEY REGULATOR OF P53 STABILITY$282,599
R01 · FY2001 · CA
MDM2/TAFII31 regulation of p53 stability$237,979
P01 · FY2001 · CA
GSTPI--A REGULATOR OF JNK SIGNALING$353,806
R01 · FY2000 · CA
UV INDUCIBLE INHIBITION IN MELANOMA$321,408
R01 · FY2000 · CA
FUNCTION OF ATF2--URE BINDING PROTEIN IN HUMAN MELANOMA$311,960
R01 · FY2000 · CA
JNK AS KEY REGULATOR OF P53 STABILITY$274,368
R01 · FY2000 · CA
MDM2/TAFII31 regulation of p53 stability$237,979
P01 · FY2000 · CA
P13K IN RADIATION RESISTANCE OF HUMAN MELANOMA CELLS$33,000
R03 · FY2000 · TW